Pfizer Inc. is pleased to announce the assignment of a permanent HCPCS J Code for ELREXFIO™ (elranatamab-bcmm). 

HCPCS code J1323 (Injection, elranatamab-bcmm, 1 mg) has been assigned and will be effective April 1, 2024.   

Please see full prescribing information for ELREXFIO including Boxed Warning, HERE.